Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- LAUREL
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Autoimmune Disorder Inflammatory Bowel Disease (IBD) Ulcerative Colitis
Study results
LPS_GA29102_LAUREL_interim results_October2021_English
(PDF, 0.6 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_cs
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_da
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_de
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_es
(PDF, 0.3 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_fr
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_he
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_hu
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_it
(PDF, 0.3 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_pl
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_pt
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_sl
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_uk
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_October2021_English_India
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com